News & Events

Part of our mandate at EXCITE International is to keep our audience up-to-date on our activities and industry news.

Payers Advisory Committee Guidance Document

Posted Jan 31st, 2022

A priority for EXCITE International is to bring payer and health system perspectives into the early stages of developing and evaluating new technologies. The present pathway to market is disjointed in that innovators focus on regulatory requirements, only to be subsequently rejected by payers because the evidence generated for regulatory purposes fails to address the concerns of payers and health systems. There are two reasons that innovators focus on regulatory requirements. First, regulato...

Read more

EXCITE International & Izotropic Corporation Announce Partnership

Posted Apr 6th, 2021 in News

With this EXCITE partnership, Izotropic will engage with EXCITE’s global network to align the device, clinical trial design, and regulatory strategy with potential payor groups, methodologists, and expert end-users. 

Read more

2020 Summit Plans Are Underway

Posted Jan 9th, 2020 in News, Events

We are pleased to announce that plans for the annual EXCITE International Summit are underway. A more formal separate announcement will be made as soon as the Planning and Program Committees have been struck and the venue confirmed. ...

Read more

New Executive Board Member

Posted Jan 8th, 2020 in News

EXCITE International is pleased to announce the appointment of Dr. Jeff Popma to its Board. Jeff is Chair of EXCITE International’s Scientifi...

Read more

New Chair for EXCITE International Payers' Advisory Committee

Posted Aug 26th, 2019 in News

EXCITE International wishes to announce that Naomi Aronson will be stepping down as Chair of the Payers’ Advisory Committee (PAC) effective August 31st. We are, at the same time pleased to announce that Jo Carol Hiatt, Chair of the Inter-Regional New Technology Committee at Kaiser Permanente has agreed to succeed Naomi as Chair.

Read more

Work with us. EXCITE International can assist you in facilitating multi-jurisdictional clinical trials through its partnership with government, clinical experts, methodology centres and health system decision makers.